::: Transgene and Roche modify the clinical development programme for their HPV targeted immunotherapy TG4001/R3484
clinical development, Roche Pharma Development, future development, valuable additional clinical data, clinical trials, additional HPV products, promising clinical responses, phase III trials, lead clinical studies

::: US College Students Needing TB Testing Now Have the Benefit of QFT(TM)
College Students Needing TB Testing, college TB control program utilizing QFT, diagnosing TB, risk of developing active TB disease, TB exposure, TB diagnosis, TB incidence countries, TB incidence areas, incidence of TB disease, QFT testing

::: Essilor : Nomination of Hubert Sagnieres
Essilor International, Essilor of America, Essilor Laboratories of America, Chief Operating Officer of Essilor, Essilor Canada, Nomination of Hubert Sagnieres, Chief Executive Officer, President of International Marketing, lens finishing laboratories, Board of Directors

::: Arana Announces Key Anti-Inflammatory Drug Milestone
Arana Therapeutics, anti-inflammatory drug ART621, Rheumatoid arthritis trial, treat severe rheumatoid arthritis, rheumatoid arthritis indication, rheumatoid arthritis program, treatment of inflammatory diseases, ART621 works, Key Anti-Inflammatory Drug Milestone, commercialisation of ART621

::: Academic publication highlights method for stabilising the adenosine A2a G-protein coupled receptor for drug discovery studies
drug discovery studies, drug discovery approaches, adenosine A2a receptor, GPCR drug target, drug discovery company, Stabilised Receptor, Heptares Therapeutics, ß1 adrenergic receptor, adenosine A2a G-protein